Mechoulam R - Search Results

1

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.

García-Arencibia M, González S, de Lago E, Ramos JA, Mechoulam R, Fernández-Ruiz J. García-Arencibia M, et al. Among authors: mechoulam r. Brain Res. 2007 Feb 23;1134(1):162-70. doi: 10.1016/j.brainres.2006.11.063. Epub 2006 Dec 28. Brain Res. 2007. PMID: 17196181

2

Discovery and characterization of endogenous cannabinoids.

Martin BR, Mechoulam R, Razdan RK. Martin BR, et al. Among authors: mechoulam r. Life Sci. 1999;65(6-7):573-95. doi: 10.1016/s0024-3205(99)00281-7. Life Sci. 1999. PMID: 10462059 Review.

3

Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats.

Rodríguez de Fonseca F, Martín Calderón JL, Mechoulam R, Navarro M. Rodríguez de Fonseca F, et al. Among authors: mechoulam r. Neuroreport. 1994 Mar 21;5(7):761-5. doi: 10.1097/00001756-199403000-00006. Neuroreport. 1994. PMID: 7912554

4

Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice.

Fride E, Mechoulam R. Fride E, et al. Among authors: mechoulam r. Brain Res Dev Brain Res. 1996 Aug 20;95(1):131-4. doi: 10.1016/0165-3806(96)00087-9. Brain Res Dev Brain Res. 1996. PMID: 8873985

5

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J. Fernández-Ruiz J, et al. Among authors: mechoulam r. Br J Clin Pharmacol. 2013 Feb;75(2):323-33. doi: 10.1111/j.1365-2125.2012.04341.x. Br J Clin Pharmacol. 2013. PMID: 22625422 Free PMC article. Review.

6

Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.

Martín-Moreno AM, Reigada D, Ramírez BG, Mechoulam R, Innamorato N, Cuadrado A, de Ceballos ML. Martín-Moreno AM, et al. Among authors: mechoulam r. Mol Pharmacol. 2011 Jun;79(6):964-73. doi: 10.1124/mol.111.071290. Epub 2011 Feb 24. Mol Pharmacol. 2011. PMID: 21350020 Free PMC article.

7

Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.

Espejo-Porras F, Fernández-Ruiz J, Pertwee RG, Mechoulam R, García C. Espejo-Porras F, et al. Among authors: mechoulam r. Neuropharmacology. 2013 Dec;75:155-63. doi: 10.1016/j.neuropharm.2013.07.024. Epub 2013 Aug 4. Neuropharmacology. 2013. PMID: 23924692

8

Cannabinoids in health and disease.

Kogan NM, Mechoulam R. Kogan NM, et al. Among authors: mechoulam r. Dialogues Clin Neurosci. 2007;9(4):413-30. doi: 10.31887/DCNS.2007.9.4/nkogan. Dialogues Clin Neurosci. 2007. PMID: 18286801 Free PMC article. Review.

9

Cannabinoids: between neuroprotection and neurotoxicity.

Sarne Y, Mechoulam R. Sarne Y, et al. Among authors: mechoulam r. Curr Drug Targets CNS Neurol Disord. 2005 Dec;4(6):677-84. doi: 10.2174/156800705774933005. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 16375685 Review.

10

Plant cannabinoids: a neglected pharmacological treasure trove.

Mechoulam R. Mechoulam R. Br J Pharmacol. 2005 Dec;146(7):913-5. doi: 10.1038/sj.bjp.0706415. Br J Pharmacol. 2005. PMID: 16205721 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results